Abstract
The “superior vena cava (SVC) syndrome” results from an obstruction of the blood flow in the SVC due either to an external compression by a (tumoral) mass located in the mediastinum or to an intra-vascular thrombosis. Two types of SVC syndromes exist: the acute and the chronic forms. These conditions differ by the symptoms that they cause, which are related to alternate drainage pathways that may or may not have the time to develop. From a pathophysiological point of view, the SVC syndrome results in increased venous pressure in the upper part of the body, which causes facial, conjunctival swelling and head cyanosis, especially when patients lay down. In cases of acute SVC syndrome, venous return from the upper part of the body is compromised and swelling of the head is very important. Hemodynamic instability is frequent, mostly due to the absence of collateral drainage. In situations of chronic SVC obstruction, symptoms of swelling are less common and hemodynamic instability is rare, even in presence of hypotension, because the venous return to the heart is possible through collateral drainage. Therefore, with these differences in mind, the strategy for SVC obstruction management will be different. Causes of SVC obstruction are generally linked to SCLC, NSCLC, lymphoma and mediastinal diseases. Their management is decided in a multidisciplinary fashion and include a combination of systemic therapy, radiation therapy, endovascular stenting when indicated and/or surgical resection and reconstruction . Total SVC clamping to perform the surgical intervention should be limited in time to avoid cerebral edema, decreased venous return and patient hemodynamic instability. Various methods to avoid the physiopathological effects of SVC clamping have been described including jugulo-femoral bypasses, intra-field bypasses and catecholamine administration. These methods allow safe and efficient shunting during the period of SVC replacement. Most complications observed following SVC surgery are respiratory or thrombotic events. Thus, cases requiring SVC resection should be discussed to ensure that the risk sustained for venous replacement will be balanced by a real oncological benefit.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Macchiarini P. Superior Vena Cava Obstruction. In: Watson TJ, Peters JH, Patterson GA, editors, Pearsons’s thoracic & esophageal surgery, Chapter 139, 3rd ed. Cambridge: Elsevier;2008. p. 1684–96. http://www.clinicalkey.com.
He C, Choong CKC. “Superior Vena Cava Syndrome”, in ESTS textbook, Chapter 79. 329–6.
Raptopoulos V. Computed tomography of the superior vena cava. Crit Rev Diagn Imaging. 1986;25(4):373–429.
Lee DSD, Flores RM. Superior vena caval resection in lung cancer. Thorac Surg Clin. 2014;24:441–7.
Perentes JY, Erling CC, Ris HB, Corpataux JM, Magnusson L. A simple bypass technique for superior vena cava reconstruction. Interact CardioVasc Thorac Surg. 2011;12:15–9.
Schraufnagel DE, Hill R, Leech JA, Pare JA, Superior vena caval obstruction. Is it a medical emergency? Am J Med. 1981; 70(6):1169–74.
Kalra M, Gloviczki P, Andrews JC, Cherry KJ Jr, Bower TC, Panneton JM, Bjarnason H, Noel AA, Schleck C, Hamrsen WS, Canton LG, Pairolero PC. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003;38(2):215–23.
Doty JR, Flores JH, Doty DB. Superior vena cava obstruction: bypass using spiral vein graft. Ann Thorac Surg. 1999;67(4):1111–6.
Magnan PE, Thomas P, Giudicelli R, Fuentes P, Branchereau A. Surgical reconstruction of the superior vena cava. Cardiovasc Surg. 1994;2(5):598–604.
Dartevelle PG, Chapelier AR, Pastorino U, Corbi P, Lenot B, Cerrina J, Bavoux EA, Verley JM, Neveux JY. Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumours. J Thorac Cardiovasc Surg. 1991;102(2):259–65.
Spaggiari L, Galetta D, Veronesi G, Leo F, Gasparri R, Petrella F, Borri A, Pelosi G, Venturino M. Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. J Thorac Cardiovasc Surg. 2006;131:490–1.
Spaggiari L, Thomas P, Magdeleinat P, et al. Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long term results of a multicentric study. Eur J Cardiothorac Surg. 2002;21:1080–6.
Dartevelle P, Macchiarini P, Chapelier A. Technique of superior vena cava resection and reconstruction. Chest Surg Clin N Am. 1995;5:345–58.
Politi L, Crisci C, Montinaro F, Andreani M, Podzemny V, Borzellino G. Prosthetic replacement and tangential resection of the superior vena cava in chest tumors. J Cardiovasc Surg (Torino). 2007;48:363–8.
Leo F, Della Grazia L, Tullii M, Gasparri R, Borri A, Venturino M, Spaggiari L. Hemodynamic instability during superior vena cava crossclamping: predictors, management, and clinical consequences. J Thorac Cardiovasc Surg. 2007;133:1105–6.
Galatoudis Z, Soumpasis I, Vretzakis G. Anesthetic considerations for surgery involving clamping of superior vena cava. Greek E-J Perioper Med. 2005;3:49–59.
Byrne JG, Leacche M, Agnihotri AK, Paul S, Bueno R, Mathisen DJ, Sugarbaker DJ. The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. Chest. 2004;125:1581–6.
Nazari S, Moncalvo F, Zonta A, Prati U, Jemos V. Temporary intraluminal bypass for superior vena cava reconstruction after cancer invasion. Thorac Cardiovasc Surg. 1988;36:5–9.
Shimokawa S, Yamashita T, Kinjyo T, Iwamura H, Watanabe S, Moriyama Y, Taira A. Extracorporeal venous bypass: a beneficial device in operation for superior vena caval syndrome. Ann Thorac Surg. 1996;62:1863–4.
Yildizeli B, Dartevelle PG, Fadel E, et al. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Ann Thorac Surg. 2008;86:1065–75.
Suzuki K, Asamura H, Watanabe S, et al. Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. Ann Thorac Surg. 2004;78:1184–9.
Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg. 2008;47(2):372–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Perentes, J.Y., Zellweger, M., Gonzalez, M. (2020). Approaches and Surgical Techniques for Superior Vena Cava Syndrome. In: Nistor, C.E., Tsui, S., Kırali, K., Ciuche, A., Aresu, G., Kocher, G.J. (eds) Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-40679-0_49
Download citation
DOI: https://doi.org/10.1007/978-3-030-40679-0_49
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-40678-3
Online ISBN: 978-3-030-40679-0
eBook Packages: MedicineMedicine (R0)